Mehdi Hedayati, Aynaz Velayati, Iman Kareem, Meghdad Sedaghat, Golbon Sohrab, Omid Nikpayam, Khadijeh Abhari, Ehsan Hejazi
Journal: Archives of physiology and biochemistry 2023;129(6):1211-1218
PMID: 34077686
This study aimed to determine the effect of symbiotic supplementation on metabolic factors and inflammation in patients with type-2 diabetes. In this clinical trial, 50 patients with type-2 diabetes were randomly assigned to the symbiotic (containing + + and fructooligosaccharide) or placebo groups to receive one sachet daily for 12 weeks. Glycaemic Index, lipid profile, and hs-CRP were measured at the beginning and end of the study. Analysis of covariance demonstrated that fasting blood glucose (FBG), insulin, homeostatic Model Assessment for Insulin Resistance (HOMA-IR), β-cell function (HOMA-β) ( <.05) and hs-CRP ( <.05) significantly declined in the treatment group compared with the placebo group. So, the current study indicated that symbiotic supplementation could improve metabolic factors and inflammation in patients with type-2 diabetes.
Medical:
Miscellaneous:
Research Materials:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.